Perceptive Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-324,967	Closed	-$2.27M	–	110
2024 Q4	$2.27M	Sell	324,967 -384,951	-54%	-$4.23M	0.06%	84
2024 Q3	$10.3M	Hold	709,918	–	–	0.22%	70
2024 Q2	$51.8M	Hold	709,918	–	–	1.25%	22
2024 Q1	$42M	Hold	709,918	–	–	0.74%	46
2023 Q4	$52M	Buy	709,918 +206,020	+41%	+$8.47M	1.16%	26
2023 Q3	$19.6M	Hold	503,898	–	–	0.66%	43
2023 Q2	$29.1M	Hold	503,898	–	–	0.84%	39
2023 Q1	$32.8M	Hold	503,898	–	–	0.97%	33
2022 Q4	$13.9M	Hold	503,898	–	–	0.4%	51
2022 Q3	$14.7M	Hold	503,898	–	–	0.43%	53
2022 Q2	$9.68M	Buy	503,898 +142,857	+40%	+$7.18M	0.3%	61
2022 Q1	$29.3M	Hold	361,041	–	–	0.59%	43
2021 Q4	$33.1M	Hold	361,041	–	–	0.51%	50
2021 Q3	$45.1M	Hold	361,041	–	–	0.66%	38
2021 Q2	$40.8M	Hold	361,041	–	–	0.53%	48
2021 Q1	$54.7M	Buy	361,041 +20,000	+6%	+$2.77M	0.73%	42
2020 Q4	$39.3M	Hold	341,041	–	–	0.42%	54
2020 Q3	$26.4M	Hold	341,041	–	–	0.39%	60
2020 Q2	$37.5M	Hold	341,041	–	–	0.61%	39
2020 Q1	$37.3M	Hold	341,041	–	–	0.97%	24
2019 Q4	$52M	Hold	341,041	–	–	1.04%	21
2019 Q3	$50.3M	Hold	341,041	–	–	1.36%	20
2019 Q2	$39.6M	Hold	341,041	–	–	0.91%	28
2019 Q1	$38.5M	Hold	341,041	–	–	1.09%	26
2018 Q4	$27.8M	Hold	341,041	–	–	1.06%	26
2018 Q3	$55.4M	Hold	341,041	–	–	1.48%	23
2018 Q2	$67.3M	Buy	+341,041	New	+$66.8M	1.76%	13

Other funds holding VRCA